← Back to Patent Explorer
US3971793A Expired / Lapsed US ⏱️ 0.0 years remaining

Certain 6-(dialkylamino, pyrrolidino and piperidino)ethoxy-4,7-dimethoxy-5-(3-phenyl-1-hydroxypropyl)2,3-dihydrobenzofurans

Assignee: Synthelabo SA
•
Filing: 1974-02-01
•
Granted: 1976-07-27
•
Expires: 1994-02-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A compound of the formula IN WHICH R is hydrogen, hydroxy, halogen or alkoxy containing up to 3 carbon atoms, and R1 -N ANGLE R2 is dialkylamino in which the alkyls contain up to 3 carbon atoms, or pyrrolidino, piperidino, morpholino or hexamethyleneimino, and n is 2 or 3. The compounds are prepared by reacting R substituted benzaldehyde with a 2,3-dihydrobenzofuran derivative and then reducing that reaction product. The compounds possess antihypertensive, hypotensive, vasodilatatory, spasmolytic, diuretic, sedative, anti-arythmic and anti-inflammatory properties.

Inventors

  • 👤 Claude P. Fauran
  • 👤 Jeannine A. Eberle
  • 👤 Guy R. Bourgery
  • 👤 Guy M. Raynaud
  • 👤 Bernard M. Pourrias

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 23:17
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/86

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 14 words
A compound of the formula ##SPC7## and the pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 14 words
A compound of the formula ##SPC7## and the pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 14 words
A compound of the formula ##SPC8## and the pharmaceutically acceptable acid addition salts thereof.
Claim 4
Dependent Claim 14 words
A compound of the formula ##SPC8## and the pharmaceutically acceptable acid addition salts thereof.
Claim 5
Dependent Claim 14 words
A compound of the formula ##SPC9## and the pharmaceutically acceptable acid addition salts thereof.
Claim 6
Dependent Claim 14 words
A compound of the formula ##SPC9## and the pharmaceutically acceptable acid addition salts thereof.
Claim 7
Dependent Claim 14 words
A compound of the formula ##SPC10## and the pharmaceutically acceptable acid addition salts thereof.
Claim 8
Dependent Claim 14 words
A compound of the formula ##SPC10## and the pharmaceutically acceptable acid addition salts thereof.
Claim 9
Dependent Claim 14 words
A compound of the formula ##SPC11## and the pharmaceutically acceptable acid addition salts thereof.
Claim 10
Dependent Claim 14 words
A compound of the formula ##SPC11## and the pharmaceutically acceptable acid addition salts thereof.
Claim 11
Dependent Claim 14 words
A compound of the formula ##SPC12## and the pharmaceutically acceptable acid addition salts thereof.
Claim 12
Dependent Claim 14 words
A compound of the formula ##SPC12## and the pharmaceutically acceptable acid addition salts thereof.
Claim 13
Dependent Claim 14 words
A compound of the formula ##SPC13## and the pharmaceutically acceptable acid addition salts thereof.
Claim 14
Dependent Claim 14 words
A compound of the formula ##SPC13## and the pharmaceutically acceptable acid addition salts thereof.
Claim 15
Dependent Claim 14 words
A compound of the formula ##SPC14## and the pharmaceutically acceptable acid addition salts thereof.
Claim 16
Dependent Claim 14 words
A compound of the formula ##SPC14## and the pharmaceutically acceptable acid addition salts thereof.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-07-27 1980-01-26 1980-07-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-07-27 1984-01-26 1984-07-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-07-27 1988-01-26 1988-07-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag